FDA.reportPublic FDA data

NDC 59930-1575-1 - betamethasone dipropionate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
59930-1575
Requested NDC
59930-1575-1
Package NDCs from labels
59930-1575-1, 59930-1575-3
Manufacturer
Warrick Pharmaceuticals Corporation
Effective date
2006-12-07
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
betamethasone dipropionate - Warrick Pharmaceuticals CorporationWarrick Pharmaceuticals Corporation2006-12-07HUMAN PRESCRIPTION DRUG LABELING

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59930-1575-1betamethasone dipropionate15 g in 1 TUBEOINTMENT151
59930-1575-1betamethasone dipropionate1 in 1 BOXOINTMENT11
59930-1575-3betamethasone dipropionate50 g in 1 TUBEOINTMENT501
59930-1575-3betamethasone dipropionate1 in 1 BOXOINTMENT11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59930-1575BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION]14 package rows20070126_686B528E-5480-4CAA-8FF4-B1BAAF5983EC.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
betamethasone dipropionateACTIVE INGREDIENT826Y60901UBETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION] 1 VEHICLE AUGMENTS THE PENETRATION OF THE STEROID. 11
betamethasoneACTIVE MOIETY9842X06Q6MBETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION] 1 VEHICLE AUGMENTS THE PENETRATION OF THE STEROID. 11
propylene glycolINACTIVE INGREDIENT6DC9Q167V3BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION] 1 VEHICLE AUGMENTS THE PENETRATION OF THE STEROID. 11
propylene glycol stearateINACTIVE INGREDIENTBETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION] 1 VEHICLE AUGMENTS THE PENETRATION OF THE STEROID. 11
white petrolatumINACTIVE INGREDIENTBETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION] 1 VEHICLE AUGMENTS THE PENETRATION OF THE STEROID. 11
white waxINACTIVE INGREDIENTBETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE) OINTMENT [WARRICK PHARMACEUTICALS CORPORATION] 1 VEHICLE AUGMENTS THE PENETRATION OF THE STEROID. 11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Betamethasone dipropionateBETAMETHASONE DIPROPIONATEA-S Medication Solutionsb5291e39-40a0-4362-9281-97f5fb4025d92026-05-11Warnings, Adverse reactionsExact identifier
rxcui: 848180
Betamethasone DipropionateBETAMETHASONE DIPROPIONATEE. Fougera & Co. a division of Fougera Pharmaceuticals, LLC853399f8-95a7-41f3-80e7-7ed8e3ff1a5e2026-01-30Warnings, Adverse reactionsExact identifier
rxcui: 848180
Betamethasone DipropionateBETAMETHASONE DIPROPIONATEPrasco Laboratoriesf5b50c00-cc6f-4296-a9ae-b16888cef4dd2025-11-19Warnings, Adverse reactionsExact identifier
rxcui: 848180
DIPROLENEBETAMETHASONE DIPROPIONATEOrganon LLC0b9543ad-2ca7-430d-aef9-81c376dc2e6c2025-11-19Warnings, Adverse reactionsExact identifier
rxcui: 848180
Betamethasone dipropionateBETAMETHASONE DIPROPIONATELupin Pharmaceuticals, Inc.216d5b7f-4236-4882-b899-be17cb1a15842025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 848180
Betamethasone DipropionateBETAMETHASONE DIPROPIONATEA-S Medication Solutions018fcec3-bfb4-451c-9b54-d1fd389c2a442025-03-14Warnings, Adverse reactionsExact identifier
rxcui: 848180
BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATEBurel Pharmaceuticals, LLCc8bda9a8-4dec-4084-84e5-4b4623390bd82024-12-04Warnings, Adverse reactionsExact identifier
rxcui: 848180
BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATEAurobindo Pharma Limitede0e0baea-1744-4708-bda7-4ab7783a3fb42024-06-05Warnings, Adverse reactionsExact identifier
rxcui: 848180
Betamethasone DipropionateBETAMETHASONE DIPROPIONATEActavis Pharma, Inc.af8317d7-b280-4f40-ad88-802f99d33d782023-02-14Warnings, Adverse reactionsExact identifier
rxcui: 848180
686B528E-5480-4CAA-8FF4-B1BAAF5983EC686B528E-5480-4CAA-8FF4-B1BAAF5983EC2006-12-07Adverse reactionsExact identifier
spl id: 686B528E-5480-4CAA-8FF4-B1BAAF5983EC
spl set id: 686B528E-5480-4CAA-8FF4-B1BAAF5983EC

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.